The global Drug Discovery AI Tools market size is predicted to grow from US$ 1895 million in 2025 to US$ 6505 million in 2031; it is expected to grow at a CAGR of 22.8% from 2025 to 2031.

Artificial intelligence(AI) in life sciences refers to the application of artificial intelligence technology to life science research and practice, and the improvement of the efficiency, accuracy and depth of life science research through computer simulation, big data analysis, machine learning, etc. This field covers a wide range of aspects, from the collection, processing and analysis of biological information to drug development, clinical and molecular diagnosis, clinical trials, etc. This report mainly focuses on drug discovery AI tools. AI can be used effectively in different parts of drug discovery, including drug target identification, compound screening, drug efficacy prediction, and clinical trial optimization..

United States market for Drug Discovery AI Tools is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Drug Discovery AI Tools is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Drug Discovery AI Tools is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Drug Discovery AI Tools players cover Atomwise, BenevolentAI, Recursion, Exscientia, Insilico Medicine, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information) newest research report, the ?Drug Discovery AI Tools Industry Forecast? looks at past sales and reviews total world Drug Discovery AI Tools sales in 2024, providing a comprehensive analysis by region and market sector of projected Drug Discovery AI Tools sales for 2025 through 2031. With Drug Discovery AI Tools sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Discovery AI Tools industry.

This Insight Report provides a comprehensive analysis of the global Drug Discovery AI Tools landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Drug Discovery AI Tools portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Drug Discovery AI Tools market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Discovery AI Tools and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Discovery AI Tools.

This report presents a comprehensive overview, market shares, and growth opportunities of Drug Discovery AI Tools market by product type, application, key players and key regions and countries.

Segmentation by Type:

    Drug Target Identification
    Compound Screening
    Efficacy Prediction
    Clinical Trial Optimization

Segmentation by Application:

    Contract Research Organizations
    Research Centers and Academic Institutes
    Pharmaceutical and Biotechnology Companies

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration.

    Atomwise
    BenevolentAI
    Recursion
    Exscientia
    Insilico Medicine
    Valo Health
    Owkin
    XtalPi
    Healx